Jack Poso šŗšø on X: "Does Jill really want to talk about what the trans doctors were doing to kids in the Weimar Republic?" / X
Does Jill really want to talk about what the trans doctors were doing to kids in the Weimar Republic? https://t.co/GNddQGIpm3ā Jack Poso šŗšø (@JackPosobiec) March 27, 2024
Remember when Pittsburgh Police announced they will be cutting down their hours, will stop responding to certain calls, and will not have police stations open in middle of the night?Well this is what they're up to now. They're putting their energy into celebrating pride andā¦ pic.twitter.com/lrTV05oWc1ā Libs of TikTok (@libsoftiktok) March 28, 2024
Stephen A. Smith | PBD Podcast | Ep. 385 - YouTube
Patrick Bet-David, Adam Sosnick, and Vincent Oshana are joined by Stephen A. Smith as they discuss Stephen A.'s love of Presidential Debates, whether Stephen A. will vote for Donald Trump in 2024, and what caused the rift between Michael Jordan and Scottie Pippen.
Purchase Stephen A. Smith's book "Straight Shooter": https://bit.ly/3VxTCmX
Follow Stephen A. Smith on Instagram: https://bit.ly/3TwZASF
Subscribe to Stephen A. Smith's YouTube channel: https://bit.ly/4afYZvF
00:06 - Show Intro
3:37 - Stephen A Smith discusses when he started speaking out about politics.
11:01 - Stephen A. explains what media outlets he watches to get his political news.
15:08 - The mistakes Don Lemon made during his contract negotiations with Elon Musk and X.
20:24 - The influence Stephen A.'s mother had on his career and political opinion.
35:07 - Stephen A. explains if Democrats are losing to Trump in the run-up to the 2024 Presidential election.
48:38 - What would happen if Stephen A. voted for Trump in 2024?
1:03:26 - Did the Civil Rights Act of 1964 win Democrats the black vote for the next 200 years?
1:41:26 - Stephen A. on the rift between Michael Jordan and Scottie Pippen.
Buy two PBD Podcast or Valuetainment mugs, get a third FREE! Use promo code "pbdmugs" at checkout: https://bit.ly/3TBAMsq
Purchase tickets to PBD Podcast LIVE! w/ Tulsi Gabbard on April 25th: https://bit.ly/3VmuaRm
Connect one-on-one with the right expert for you on Minnect: https://bit.ly/3MC9IXE
Connect with Patrick Bet-David on Minnect: https://bit.ly/3OoiGIC
Connect with Adam Sosnick on Minnect: https://bit.ly/42mnnc4
Connect with Tom Ellsworth on Minnect: https://bit.ly/3UgJjmR
Connect with Vincent Oshana on Minnect: https://bit.ly/47TFCXq
Purchase Patrick's new book "Choose Your Enemies Wisely": https://bit.ly/41bTtGD
Register to win a Valuetainment Boss Set (valued at over $350): https://bit.ly/41PrSLW
Get best-in-class business advice with Bet-David Consulting: https://bit.ly/40oUafz
Visit VT.com for the latest news and insights from the world of politics, business and entertainment: https://bit.ly/472R3Mz
Visit Valuetainment University for the best courses online for entrepreneurs: https://bit.ly/47gKVA0
Text āPODCASTā to 310-340-1132 to get the latest updates in real-time!
Get PBD's Intro Song "Sweet Victory" by R-Mean: https://bit.ly/3T6HPdY
SUBSCRIBE TO:
@VALUETAINMENT
@vtsoscast
@ValuetainmentComedy
@bizdocpodcast
@theunusualsuspectspodcast
Want to be clear on your next 5 business moves? https://bit.ly/3Qzrj3m
Join the channel to get exclusive access to perks: https://bit.ly/3Q9rSQL
Download the podcasts on all your favorite platforms https://bit.ly/3sFAW4N
Patrick Bet-David is the founder and CEO of Valuetainment Media. He is the author of the #1 Wall Street Journal Bestseller āYour Next Five Movesā (Simon & Schuster) and a father of 2 boys and 2 girls. He currently resides in Ft. Lauderdale, Florida.
Get Your Sheath Underwear at https://sheathunderwear.com/JPREACTS Use Code 'JPREACTS' for 20% off your order! Get Your Freedom Merch Here - https://bit.ly/3iPkRse See my LIVE Comedy Shows - https://aw
Adjusting for timeādependent sensitivity in an illnessādeath model, with application to motherātoāchild transmission of HIV - Teeple - 2015 - Statistics in Medicine - Wiley Online Library
In mother-to-child transmission of HIV, identifying infected infants relies on a diagnostic test with imperfect sensitivity that is administered at scheduled visits. Under this scenario, a participan...
Non-parametric maximum likelihood estimation of interval-censored failure time data subject to misclassification | SpringerLink
Statistics and Computing - The paper considers non-parametric maximum likelihood estimation of the failure time distribution for interval-censored data subject to misclassification. Such data can...
Diagnostic accuracy of coronary angiography and risk factors... : Transplantation
1-year survivors of heart transplantation underwent 2,168 angiograms and were classified as having no CAV (0% stenosis), mild-moderate CAV (up to 70% stenosis), or severe CAV (>70% stenosis). We used serial measurements of stenosis to estimate the diagnostic accuracy of angiography and to assess the following risk factors for CAV onset, progression, and survival: recipient and donor age and sex, preoperative ischemic heart disease (IHD), acute rejection rates, cytomegalovirus (CMV) infection, and serologic status. CAV was diagnosed by angiography in 248 of 556 (45%) 1-year survivors, with a mean onset time of 8.6 years. Patients spent a mean of 3.4 years with mild-moderate disease and 3.4 years with severe disease before death. Angiography specificity was 97.8%, and sensitivity was 79.3%. The following variables were found to significantly increase the risk of CAV onset: recipient age relative rate (95% confidence interval) 1.16 (1.01ā1.34), donor age by 1.27 (1.13ā1.43), male recipient by 2.00 (1.11ā2.57), pretransplant IHD by 1.75 (1.30ā2.36), cumulative rejection by 1.13 (1.05ā1.21), and CMV infection by 1.42 (1.06ā1.92). Acute rejection increased risk of death by 1.48 (1.19ā1.85). Angiography is highly specific and moderately sensitive for diagnosis of CAV. Risk of CAV onset is related to donor age and recipient history of pretransplant IHD and is further increased by immune-related insults of acute rejection and CMV infection....
Likelihood based inference for current status data on a grid: A boundary phenomenon and an adaptive inference procedure
In this paper, we study the nonparametric maximum likelihood estimator for an event time distribution function at a point in the current status model with observation times supported on a grid of potentially unknown sparsity and with multiple subjects sharing the same observation time. This is of interest since observation time ties occur frequently with current status data. The grid resolution is specified as cnāĪ³ with c > 0 being a scaling constant and Ī³ > 0 regulating the sparsity of the grid relative to n, the number of subjects. The asymptotic behavior falls into three cases depending on Ī³: regular Gaussian-type asymptotics obtain for Ī³ < 1/3, nonstandard cube-root asymptotics prevail when Ī³ > 1/3 and Ī³ = 1/3 serves as a boundary at which the transition happens. The limit distribution at the boundary is different from either of the previous cases and converges weakly to those obtained with Ī³ ā (0, 1/3) and Ī³ ā (1/3, ā) as c goes to ā and 0, respectively. This weak convergence allows us to develop an adaptive procedure to construct confidence intervals for the value of the event time distribution at a point of interest without needing to know or estimate Ī³, which is of enormous advantage from the perspective of inference. A simulation study of the adaptive procedure is presented.
The Taxanes, Vinca Alkaloids, and Their Derivatives | Harrison's Manual of Oncology, 2e | AccessHemOnc | McGraw-Hill Medical
Read chapter 3 of Harrison's Manual of Oncology, 2e online now, exclusively on AccessHemOnc. AccessHemOnc is a subscription-based resource from McGraw Hill that features trusted medical content from the best minds in medicine.
Inhibition of De Novo Purine Biosynthesis and Interconversion by 6-Methylpurine in Escherichia coli
The inhibition of Escherichia coli strain B and strain W-11 by 6-methylpurine depended on the formation of 6-methylpurine ribonucleotide by the action of adenine phosphoribosyltransferase (AMP: pyrophosphate phosphoribosyltransferase, EC 2.4.2.7). 6-Methylpurine ...